Social media is increasingly changing the way consumers interact and behave. The massive growth in the reach of mobile tools adds to the trend significantly.
The world is getting more connected by the day and the possibilities it holds for healthcare organizations are countless. Consumers turn to their mobile devices to connect, collaborate and share knowledge by leveraging social media technology. Companies are increasingly turning to social media and mobile technology to actively engage their customers in real-time while on the move. Leading healthcare organizations are quickly catching on to this burgeoning trend and have started to embrace it in their efforts to provide affordable, quality, and timely care.
Social media and mobile technology are playing a large role in shaping the future of healthcare and are redefining the way care has been delivered for centuries. These collaborative technologies are transforming several critical aspects of the healthcare industry including the following:
Carl Ascenzo is Vice President of Global Healthcare Solutions for Virtusa.
Social media transforming healthcare interactions
Social media is moving beyond the solely social sphere to influence engagement and outcomes.
Social media is increasingly changing the way consumers interact and behave. The massive growth in the reach of mobile tools adds to the trend significantly.
The world is getting more connected by the day and the possibilities it holds for healthcare organizations are countless. Consumers turn to their mobile devices to connect, collaborate and share knowledge by leveraging social media technology. Companies are increasingly turning to social media and mobile technology to actively engage their customers in real-time while on the move. Leading healthcare organizations are quickly catching on to this burgeoning trend and have started to embrace it in their efforts to provide affordable, quality, and timely care.
Social media and mobile technology are playing a large role in shaping the future of healthcare and are redefining the way care has been delivered for centuries. These collaborative technologies are transforming several critical aspects of the healthcare industry including the following:
Carl Ascenzo is Vice President of Global Healthcare Solutions for Virtusa.
FDA Updates for Week of May 13: First Bispecific Antibody for Solid Tumor
May 18th 2024The FDA has approved a new type of bispecific antibody to treat small cell lung cancer and an additional indication for Breyanzi for patients with follicular lymphoma. The agency has set review date for gene therapy for enzyme deficiency. In addition, Biogen have Eisai hve begun a rolling submission of subcutaneous Leqembi for Alzheimer’s disease.
Read More
Meet the Board: Navigating the Evolving Landscape of Healthcare Coverage and Pharmacy Benefits with Marci Chodroff of Magellan, Prime Therapeutics
May 8th 2024This month's episode of the Meet the Board podcast features a new member of our editorial advisory board, Marci J. Chodroff, MD, FACP, vice president of Medical Affairs at Magellan Rx Management, a Prime Therapeutics company.
Listen
AI on the Agenda at 2024 ATS, Says Conference Chair | 2024 ATS
May 18th 2024Debra Boyer, M.D., M.H.P.E., discussed the program of the 2024 American Thoracic Society International Conference in San Diego and the limits of artificial intelligence.
Read More
DC Roundtable Video: Patrick Cooney on PBM Legislation in Washington
April 12th 2024Listen
Omega-3s For Dry Eye Disease? Not the Answer According to This Study
May 17th 2024Some research has suggested that omega-3 fatty acid supplements could help treat dry eye disease. But Korean investigators reported results from a randomized clinical trial this week in JAMA Ophthalmology tthat showed no benefit.
Read More
AI Innovating Pregnancy Care and Cancer Screening
May 17th 2024According to findings collected by Cedars-Sinai, artificial intelligence can reduce serious health risks associated with pregnancy and childbirth, and improve screening for some gynecological cancers.
Read More
FDA Updates for Week of May 13: First Bispecific Antibody for Solid Tumor
May 18th 2024The FDA has approved a new type of bispecific antibody to treat small cell lung cancer and an additional indication for Breyanzi for patients with follicular lymphoma. The agency has set review date for gene therapy for enzyme deficiency. In addition, Biogen have Eisai hve begun a rolling submission of subcutaneous Leqembi for Alzheimer’s disease.
Read More
Meet the Board: Navigating the Evolving Landscape of Healthcare Coverage and Pharmacy Benefits with Marci Chodroff of Magellan, Prime Therapeutics
May 8th 2024This month's episode of the Meet the Board podcast features a new member of our editorial advisory board, Marci J. Chodroff, MD, FACP, vice president of Medical Affairs at Magellan Rx Management, a Prime Therapeutics company.
Listen
AI on the Agenda at 2024 ATS, Says Conference Chair | 2024 ATS
May 18th 2024Debra Boyer, M.D., M.H.P.E., discussed the program of the 2024 American Thoracic Society International Conference in San Diego and the limits of artificial intelligence.
Read More
DC Roundtable Video: Patrick Cooney on PBM Legislation in Washington
April 12th 2024Listen
Omega-3s For Dry Eye Disease? Not the Answer According to This Study
May 17th 2024Some research has suggested that omega-3 fatty acid supplements could help treat dry eye disease. But Korean investigators reported results from a randomized clinical trial this week in JAMA Ophthalmology tthat showed no benefit.
Read More
AI Innovating Pregnancy Care and Cancer Screening
May 17th 2024According to findings collected by Cedars-Sinai, artificial intelligence can reduce serious health risks associated with pregnancy and childbirth, and improve screening for some gynecological cancers.
Read More